JOSÉ UBEROS FERNÁNDEZ-rekin lankidetzan egindako argitalpenak (42)

2021

  1. Methylphenidate ameliorates the homeostatic balance between levels of kynurenines in ADHD children

    Psychiatry Research, Vol. 303

2020

  1. Indole Tryptophan Metabolism and Cytokine S100B in Children with Attention-Deficit/Hyperactivity Disorder: Daily Fluctuations, Responses to Methylphenidate, and Interrelationship with Depressive Symptomatology

    Journal of Child and Adolescent Psychopharmacology, Vol. 30, Núm. 3, pp. 177-188

2019

  1. Early monitoring of fatty acid profile in children with attention deficit and/or hyperactivity disorder under treatment with omega-3 polyunsaturated fatty acids

    Minerva Pediatrica, Vol. 71, Núm. 3, pp. 313-325

2017

  1. BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology

    Psychopharmacology, Vol. 234, Núm. 2, pp. 267-279

  2. Probiotics to prevent necrotising enterocolitis and nosocomial infection in very low birth weight preterm infants

    British Journal of Nutrition, Vol. 117, Núm. 7, pp. 994-1000

2014

  1. Differential responses of two related neurosteroids to methylphenidate based on ADHD subtype and the presence of depressive symptomatology

    Psychopharmacology, Vol. 231, Núm. 17, pp. 3635-3645

  2. Methylphenidate ameliorates depressive comorbidity in ADHD children without any modification on differences in serum melatonin concentration between ADHD subtypes

    International Journal of Molecular Sciences, Vol. 15, Núm. 9, pp. 17115-17129

2013

  1. Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD

    Journal of Psychiatric Research, Vol. 47, Núm. 3, pp. 377-383

2012

  1. Cranberry syrup vs trimethoprim in the prophylaxis of recurrent urinary tract infections among children: A controlled trial

    Open Access Journal of Clinical Trials, Vol. 4, pp. 31-38

2011

  1. Normalization of the sleep-wake pattern and melatonin and 6-sulphatoxy-melatonin levels after a therapeutic trial with melatonin in children with severe epilepsy

    Journal of Pineal Research, Vol. 50, Núm. 2, pp. 192-196

  2. Psychosocial dwarfism: Psychopathological aspects and putative neuroendocrine markers

    Psychiatry Research, Vol. 188, Núm. 1, pp. 96-101

2010

  1. Melatonin and elimination of Kynurenines in children with down's syndrome

    Journal of Pediatric Endocrinology and Metabolism, Vol. 23, Núm. 3, pp. 277-282

  2. Overweight and obesity as risk factors for the asymptomatic carrier state of Neisseria meningitidis among a paediatric population

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 29, Núm. 3, pp. 333-334

2009

  1. Effects on the glutathione pool of the insulin-induced hypoglycaemia test

    Journal of Biological Regulators and Homeostatic Agents, Vol. 23, Núm. 3, pp. 149-154

  2. Serum melatonin concentration in the child with non-organic failure to thrive: Comparison with other types of stress

    Journal of Biological Regulators and Homeostatic Agents, Vol. 23, Núm. 1, pp. 15-22

2008

  1. Influence of the antioxidant content of saliva on dental caries in an at-risk community

    British Dental Journal, Vol. 205, Núm. 2

  2. The presence of precursors of benign pre-B lymphoblasts (hematogones) in the bone marrow of a paediatric patient with cytomegalovirus infection

    Clinical Medicine: Oncology, Vol. 2, pp. 437-439

2007

  1. Longitudinal study of the simultaneous secretion of melatonin and leptin during normal puberty

    Hormone Research, Vol. 68, Núm. 1, pp. 11-19

  2. Melatonin increases following convulsive seizures may be related to its anticonvulsant properties at physiological concentrations

    Neuropediatrics, Vol. 38, Núm. 3, pp. 122-125

  3. Melatonin levels during the first week of life and their relation with the antioxidant response in the perinatal period

    Neonatology, Vol. 92, Núm. 3, pp. 209-216